Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-02 | New | $12,698,061 | $12,698,061 | Equity Only | 06b | SEC link |
| 2021-11-03 | Amended | $68,407,469 | $19,344,747 | Equity Only | 06b | SEC link |
| 2021-06-17 | Amended | $49,062,722 | $22,637,500 | Equity Only | 06b | SEC link |
| 2021-03-26 | Amended | $26,425,222 | $4,958,070 | Equity Only | 06b | SEC link |
| 2020-10-21 | New | $21,467,152 | $21,467,152 | Equity Only | 06b | SEC link |
| 2019-04-22 | Amended | $33,899,361 | $22,240,835 | Equity Only | 06b | SEC link |
| 2018-03-28 | New | $11,658,526 | $11,658,526 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Paritosh Dhawale | Director |
| Martin Driscoll | Director, Executive |
| John Dyett | Director |
| Brett Giroir | Director |
| Joydeep Goswami | Director |
| Alvaro Guillem | Director |
| Matthew Head | Executive |
| Gina Jones | Director |
| Jeff Keyser | Executive |
| Kartik Krishnan | Director, Executive |
| Melissa Paoloni | Executive |
| Yumin Qiu | Director |
| Yumin Qui | Director |
| Caleb Smith | Director |
| Ravi Srinivasan | Director, Executive |